EFTA00313848: California Cryobank Liability and Specimen Control Terms Signed by Jeffrey Epstein

UpdatedSeptember 11, 2026

ByEpsteinWiki

Snapshot

EFTA00313848 is page 2 of an eight page California Cryobank Specimen Storage Agreement naming Jeffrey Epstein as the client. This page governs the release, transfer, destruction, and potential loss of stored semen specimens or testicular samples.

EFTA00313848 does not itself contain Epstein’s signature. The signed client page appears as EFTA00313936, where Epstein signed the agreement on May 9, 2016. He also signed the automatic payment authorization preserved as EFTA00313944.

The broader agreement gave the client substantial control over the specimens while sharply limiting California Cryobank’s financial liability if specimens were lost, damaged, contaminated, spoiled, degraded, or destroyed.

The agreement confirms that Epstein completed and signed paperwork for reproductive specimen storage. It does not, standing alone, prove that a specimen was deposited, that stored material belonged biologically to Epstein, or that it was ever used to attempt a pregnancy.

Document Details

Primary evidence ID: EFTA00313848

Agreement: California Cryobank Specimen Storage Agreement

Page represented by EFTA00313848: Page 2 of 8

Client named on page 1: Jeffrey Epstein

Date signed: May 9, 2016

Signed client page: EFTA00313936

Signed automatic payment authorization: EFTA00313944

Client address: 9 East 71st Street, New York, New York 10021

Client email: jeevacation@gmail.com

Telephone number: Redacted

Social Security number: Redacted

Primary evidence: View EFTA00313848 on Epstein Data

DOJ copy: Download EFTA00313848 from the Department of Justice

Relationship to the Full Agreement

The beginning of the agreement appears in EFTA00313838. That page identifies Jeffrey Epstein as the client and describes the contemplated material as semen specimens, testicular samples, or both.

The agreement defines client specimens broadly. They could have been produced by the client or another individual. This language means the agreement alone cannot establish that every specimen covered by the contract was biologically Epstein’s.

The opening page states that the specimens were being stored for possible later implantation into a recipient for the purpose of achieving pregnancy. Processing and freezing could occur before storage.

This language establishes a reproductive purpose for the storage arrangement. It does not identify any intended recipient, egg provider, partner, surrogate, physician, clinic, or planned child.

Release of Specimens

Section 4 of EFTA00313848 governs the release of stored specimens.

California Cryobank agreed to ship specimens after receiving a written request from the client and verifying the client’s identity. The Cryobank could require whatever verification forms it considered appropriate.

The client could direct shipment either to the client or to a designated medical facility. Shipment would occur through a commercial carrier.

Under the agreement, the specimens were considered retrieved by the client as soon as the commercial carrier accepted them. Responsibility for the specimens during and after shipment then shifted to the client.

This provision is significant because it established when California Cryobank’s custody ended and when the client assumed responsibility for transportation risks.

The document does not show that Epstein ever requested a shipment or transfer.

Termination and Destruction

Section 5 identifies several events that could terminate the agreement:

California Cryobank could terminate storage if it determined that the specimens were unsuitable for storage.
The client could direct the Cryobank to terminate the agreement and destroy all stored specimens.
The client could direct the Cryobank to transfer the specimens to another facility.
The agreement could terminate following notification of the client’s death and disposition of the specimens under the client’s selected instructions.
California Cryobank could terminate the agreement following a payment default.

Except for the limited refund described when California Cryobank rejected specimens as unsuitable, the agreement generally provided no refund of storage or other fees following termination.

When the agreement terminated, California Cryobank’s storage obligations ended. If the client or legal representative did not provide proper disposition instructions, the client was required to retrieve any remaining specimens within 30 calendar days.

If the specimens were not retrieved during that period, California Cryobank could discard some or all of them at its sole discretion.

Risks Accepted by the Client

Section 6 describes risks associated with collecting, testing, processing, freezing, storing, shipping, and thawing semen.

The listed risks include:

Damage to sperm.
Reduced capacity for fertilization.
Reduced life span after thawing.
Loss of some or all specimens.
Degradation.
Spoilage.
Contamination.
Damage caused by fire or power failure.
Damage caused by a natural disaster.
Damage connected to terrorism or war.

The agreement states that California Cryobank did not guarantee against these outcomes. The disclaimer extended to losses attributed to circumstances beyond the company’s control and, according to the contract language, certain losses attributed to the Cryobank’s own negligence.

The page reflects contractual terms. It does not establish that any loss, contamination, damage, or destruction actually occurred.

Limitation of Financial Liability

The agreement sharply limited the compensation available if specimens were lost, injured, damaged, or destroyed.

For losses caused by California Cryobank’s negligence or failure to exercise reasonable care, the stated liquidated damages were limited to the total storage fees paid for the affected specimen.

The agreement cited California Civil Code Sections 1671 and 1840 as authority for the liquidated damages provision and declared value limitation.

In practical terms, the contract attempted to limit recovery to storage fees rather than the reproductive, personal, medical, or emotional value a client might assign to the material.

This article documents what the agreement says. It does not offer a legal conclusion about whether every limitation would have been enforceable under every possible circumstance.

Control During Epstein’s Lifetime

The broader agreement states that the client was the sole owner of client specimens stored under the contract.

According to EFTA00313901, the client could give or transfer specimens to another person during storage if California Cryobank received written notice and the recipient accepted the agreement’s terms or signed a new storage agreement.

The agreement also represented that the services were intended solely for personal use and not for resale, redistribution, or another commercial purpose.

These provisions gave the client control over:

Continued storage.
Destruction.
Transfer to another facility.
Release to a designated medical facility.
A gift or transfer to another person.
Instructions governing disposition after death.

The agreement does not document Epstein exercising any of these transfer rights.

Epstein’s Instructions After Death

The post death instructions appear in EFTA00313873.

The form offered two choices. The client could direct California Cryobank to discard the specimens after death, or the client could direct their release to a legal representative, executor, or administrator of the estate.

The second option is visibly marked. Under that option, the specimens were to be released to the client’s legal representative, who would then provide instructions concerning their disposition.

Before release, the legal representative would be required to provide:

A copy of the client’s death certificate.
Verification of legal authority to represent the estate.
An indemnification agreement if California Cryobank required one.
Compliance with laws and regulations governing specimen testing and release.

The agreement allowed California Cryobank to refuse release until it was satisfied with the representative’s identity and authority.

If the Cryobank could not carry out the selected instructions after using reasonable efforts for 30 days following notice of the client’s death, it retained the right to destroy the specimens.

The page does not show what happened after Epstein died on August 10, 2019. No released record reviewed for this article confirms whether California Cryobank still held specimens, whether the estate requested them, or whether they were released or destroyed.

Confidentiality Terms

Section 8 states that California Cryobank would use reasonable efforts to protect information provided by the client.

The confidentiality provision contained broad exceptions, including:

Disclosures required by law.
Requests from government agencies or public authorities.
Accidental disclosures.
Disclosures associated with media attention.
Unauthorized access by hackers or other intruders.
Disclosures to hospitals, laboratories, and health care providers.
Disclosures to professional consultants and advisers.
Disclosures connected to the sale, transfer, or assignment of California Cryobank’s business.

The provision therefore promised reasonable confidentiality efforts but did not guarantee complete secrecy.

Arbitration and Governing Law

EFTA00313901 states that California law governed the agreement and that Los Angeles was the designated location for disputes.

EFTA00313920 required disputes to be resolved through arbitration. If the parties could not agree on an arbitrator, the contract designated ADR Services or, if unavailable, the American Arbitration Association.

The agreement also called for information connected to a dispute to remain confidential.

The contract said its provisions would bind the parties and their heirs, spouses, executors, administrators, representatives, successors, and permitted assigns.

Epstein’s Signature

The client signature page is preserved as EFTA00313936.

The page contains:

A handwritten date of May 9, 2016.
A signature in the client section.
The handwritten name Jeffrey Epstein.
The address 9 East 71st Street in New York.
The email address jeevacation@gmail.com.
A redacted telephone number.
A redacted Social Security number.

The California Cryobank signature section appears blank in the released image. This article does not make a legal determination about whether a separate company signature existed or whether the client’s signature alone activated the storage arrangement.

Automatic Payment Authorization

The final page appears as EFTA00313944.

Epstein signed an authorization allowing California Cryobank to charge a provided credit card for monthly specimen storage fees. The authorization states that monthly charges would continue until the agreement was terminated or the client entered a prepaid storage arrangement.

The page contains Epstein’s handwritten name, signature, and the date May 9, 2016.

The account number field appears blank in the released copy. The credit card number and billing details are not visible.

The signed payment authorization demonstrates preparation for continuing storage charges. It does not prove how many charges were processed or how long the account remained active.

Administrative Trail

The signed agreement is supported by related email records from May 9, 2016.

EFTA00534037 contains an email from a California Cryobank client deposit coordinator providing information about the company’s semen storage program. The email included the storage agreement, depositor forms, infectious disease information, testing consent forms, a request for laboratory results, and a semen storage information packet.

In EFTA00567124, Karyna Shuliak forwarded the Cryobank materials to Lesley Groff. Shuliak wrote that Epstein wanted Groff to complete the attached forms.

EFTA00567420 preserves another appearance of that forwarded message.

These records show that Shuliak and Groff handled administrative paperwork associated with the Cryobank inquiry. They do not establish that either woman was an intended recipient of reproductive material or planned to have a child with Epstein.

Connection to Epstein’s Sperm Banking Inquiry

A related email, EFTA00827984, records Epstein asking about sperm banking in 2016.

Other communications indicate that Epstein received information about the need for a medical prescription and an in person visit before depositing specimens. The California Cryobank paperwork shows that the inquiry advanced into completed contractual documents.

The records establish an active effort to arrange reproductive specimen storage. They still do not provide a laboratory receipt, specimen inventory, deposit confirmation, accession number, test result, or record showing that stored material was used.

What the Evidence Establishes

The combined records establish that:

Epstein was named as the client in a California Cryobank Specimen Storage Agreement.
The agreement concerned semen specimens, testicular samples, or both.
The contract contemplated storage for possible later implantation to achieve pregnancy.
Epstein signed the agreement on May 9, 2016.
Epstein signed an automatic payment authorization on the same date.
The contract gave the client rights to direct release, transfer, destruction, and certain third party transfers.
The contract limited California Cryobank’s liability for loss or damage.
The post death section contains a mark selecting release to the client’s legal representative instead of immediate destruction.
Shuliak and Groff participated in transmitting and completing Cryobank paperwork.

Evidentiary Limits

The available documents do not establish:

That Epstein deposited a specimen.
That California Cryobank accepted a specimen.
The number or type of specimens stored.
That any stored specimen was biologically Epstein’s.
The results of infectious disease or fertility testing.
The identity of any intended recipient.
That any specimen was used for insemination, fertilization, embryo creation, or pregnancy.
That Epstein fathered a child through stored material.
That Shuliak or Groff was an intended recipient.
How long the account remained active.
Whether automatic payments were processed.
Whether specimens remained in storage when Epstein died.
Whether the Epstein estate requested or received any specimens.
Whether California Cryobank ultimately transferred or destroyed the material.

Evidence Appearances

The agreement is divided among separate evidence identifiers:

EFTA00313838 contains page 1, which names Jeffrey Epstein as the client and describes the intended specimen storage.
EFTA00313848 contains page 2, covering release, termination, risk acknowledgment, and liability limitations.
EFTA00313873 contains page 4, covering post death instructions and confidentiality.
EFTA00313901 contains page 5, covering ownership, third party transfer rights, and governing law.
EFTA00313920 contains page 6, covering arbitration, notices, uncontrollable events, and binding effect.
EFTA00313936 contains page 7, including Epstein’s signature and identifying information.
EFTA00313944 contains page 8, including Epstein’s signed automatic payment authorization.

The EFTA identifier corresponding to page 3 was not established from the records reviewed for this article.

Why This Document Matters

EFTA00313848 is significant because it documents the legal and financial terms under which reproductive specimens connected to Epstein’s client account could be stored, transferred, destroyed, or released.

The post death selection is especially important. The marked option contemplated release to a legal representative rather than automatic destruction. This created the possibility that control could pass to the executor or administrator of Epstein’s estate, subject to California Cryobank’s requirements and applicable law.

The documents warrant careful investigation because Epstein was a convicted sex offender whose reproductive interests have been discussed in other records and public reporting. At the same time, the agreement cannot be used as proof of a child, pregnancy, embryo, intended recipient, or completed reproductive procedure.

The strongest supported conclusion is narrower: Epstein signed a semen and testicular specimen storage agreement, accepted its liability and control terms, and authorized continuing payment.

Fact Check

Confirmed: EFTA00313848 is page 2 of a California Cryobank Specimen Storage Agreement.

Confirmed: EFTA00313848 does not contain Epstein’s signature.

Confirmed: EFTA00313838 names Jeffrey Epstein as the client.

Confirmed: The agreement contemplated semen specimens, testicular samples, or both.

Confirmed: The agreement allowed specimens produced by the client or another individual.

Confirmed: The stated reproductive purpose was possible later implantation to achieve pregnancy.

Confirmed: Epstein signed the client page on May 9, 2016.

Confirmed: Epstein signed an automatic payment authorization on May 9, 2016.

Confirmed: The client could direct release, transfer, or destruction.

Confirmed: The marked post death option directed release to a legal representative.

Confirmed: Liability for negligent loss or damage was contractually limited to aggregate storage fees paid.

Confirmed: Shuliak forwarded the Cryobank forms to Groff at Epstein’s request.

Not confirmed: That a specimen was deposited or accepted.

Not confirmed: That stored specimens were biologically Epstein’s.

Not confirmed: That any reproductive material was ever used.

Not confirmed: That any child was conceived from stored material.

Not confirmed: What happened to any specimens after Epstein’s death.

Questions Still Unanswered

Which EFTA identifier contains page 3 of the agreement?
Did California Cryobank receive a specimen from Epstein?
Was a client account number assigned?
Did the company countersign the agreement on another page or copy?
What specimens, if any, were stored?
Were those specimens biologically Epstein’s?
Were infectious disease or fertility tests completed?
How long did California Cryobank maintain the account?
Were monthly storage charges paid?
Did Epstein ever direct a transfer, shipment, gift, or destruction?
Who was the contemplated recipient mentioned in the agreement?
Did Epstein’s estate notify California Cryobank of his death?
Did an executor or administrator request control of stored specimens?
Were any specimens released, transferred, or destroyed after August 10, 2019?
Did investigators subpoena California Cryobank’s account, billing, testing, and disposition records?

Source List

Related EpsteinWiki Pages

EFTA00313848 Download

PostedFebruary 17, 2026

ByEpsteinWiki

Tags: